Member Info for 86KB

*an opportunity

Yes certainly and opportunity here, we are bouncing back up and buying under 16p will be gone soon.

Seems like they wanted to close the gap from yesterday, now done expect a bounce.

L2 is 1vs1

Having a pullback this morning which is all good. Consolidation and then we go higher. This is an opportunity for those looking to take positions to take advantage.

Actually seems like we closed at 17.7p even better.

Days high was 19.40p, we closed at 17.6p. Very happy with that finish.

More of the same tomorrow. Think we will see 20s tomorrow.

Https://youtu.be/tSUsuxcuplA?feature=shared

At first glance,

@ZaksTradersCafe

🎤 looked fairly routine. Digging deeper, though, the detail suggests ImmuPharma may be sitting on something far more significant — a development that has investors piling in.

Tim McCarthy, CEO of Immupharma, said,” With regards to deals with big pharma: “But we’re not at a standing start here. You know, we’ve got relationships already with a number of these companies. And I’ve been pleasantly surprised by, you know, the very very positive response and reactions, you know, even in the last week since we put the PATENT notice out.

So yes, we’ve laid that out in the beginning of this year. So shareholders of IMM should certainly expect a deal or deals in the plural between now and year end and frankly those deals could happen at any time between now and year end. But that’s the space we’ve given ourselves to get some deals done by the end of this year.

Gold girl come end of month I would say we will be trading 39-50p. But today we may see 21-22p if not tomorrow.

Great to see these are holding and consolidating well. Looking good for a strong afternoon.

Some don't know the reason for the rise yet, so I suggest you listen to the interviews from last week and look at rns for further information. Once done that research how big the autoimmune disease market is and how much demand there is in that area. Then you will know we still undervalued and no where near fair value. Remember we won't go up in a straight line so any dips will provide opportunity to take positions.

Personally wouldn't be selling any anytime soon as these will be trading much higher than 20s. You have to remember its a market worth $billions and this will be trading in £s. Imo.

Fantastic start, we hit 17.4p first thing. Once that is taken out we will see 21-22p.

Watch out for dips if you want in as after 11 we go higher.

Can everyone just report these posts that are not relevant here. They are just clogging up the board and useful information is getting missed by this clutter.

Https://x.com/Share_Talk/status/1966929564841767379?t=eODpJHtV2RtTyKZhEgP02Q&s=19

Onetomany changes the tone of his post based on his position. If he is in you will suddenly see some positive posts, but doesn't hold for long so you miss them kind of posts. Once sold he goes all negative and bombards this chat board with L2 not looking great, deal already priced in, blah blah.

Everytime he said L2 was looking weak the share price has done the opposite to what he has said, so pay no attention to him when he talks about L2.

Any weakness has always been taking up by buyers waiting on the sidelines so we don't have a pullback for long.

Word is getting out and come Monday we shall get more interest.

Put simply, P140 is being repurposed to correct an overactive immune system without weakening the body’s natural defences.

The patent, which could secure 20 years of protection, covers both the therapy and a new diagnostic test aimed at patients with a recently defined ‘Type M’ immune disorder.

This dual approach could speed diagnosis, sharpen trial results and widen the scope of P140 across as many as 50 autoimmune conditions.

By offering a way to restore immune balance without the side effects of conventional immunosuppressants, the drug has been hailed as a potential breakthrough.

https://www.thisismoney.co.uk/money/markets/article-15092075/SMALL-CAP-MOVERS-Lupus-drug-patent-lights-market.html

Tim McCarthy, CEO of Immupharma said" shareholders of IMM should certainly expect a deal or deals in the plural between now and year end and frankly those deals could happen at any time between now and year end

Listen 🦻

@ImmuPharma

Interview Today 🎤 24:34 #IMM With regards deals with big pharma: “But we're not at a standing start here. You know, we've got relationships already with a number of these companies. And I've been pleasantly surprised by, you know, the very very positive response and reactions, you know, even in the last week since we put the PATENT notice out.

So yes, we've laid that out in the beginning of this year. So shareholders of IMM should certainly expect a deal or deals in the plural between now and year end and frankly those deals could happen at any time between now and year end. But that's the space we've given ourselves to get some deals done by the end of this year.”

https://share-talk.com/tim-mccarthy-chief-executive-officer-of-immupharma-plc-talks-to-zak-mir/ via

@ZaksTradersCafe

Very happy with that finish, people will digest whats coming here once they listen to the interview again this evening and over the weekend. Next week we will see a strong start from the get go and form new base in 20s. GLA.